Skip to main content
Clinical Trials/ITMCTR2100004306
ITMCTR2100004306
Recruiting
未知

Acupuncture for Urinary Incontinence in Patients With Prostate Cancer Surgery: a Multicenter, Single-Blinded, Randomized, Parallel-Controlled Trial

ConditionsProstate cancer

Overview

Phase
未知
Intervention
Not specified
Conditions
Prostate cancer
Sponsor
The First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional study
Sex
Male

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Meet the diagnostic criteria for prostate cancer;
  • 2\. Meet the diagnostic criteria for urinary incontinence (1\), (2\), (3\), (4\);
  • 3\. Karnofsky score \>\= 60 points or ECOG 0\-1 points;
  • 4\. Aged \>\= 18 years;
  • 5\. Sign informed consent.

Exclusion Criteria

  • 1\.Urgent urinary incontinence caused by detrusor hyperreflexia and bladder spasm, and urinary incontinence caused by central or endocrine factors;
  • 2\.Urinary incontinence was treated after cystostomy, reconstruction of urethral sphincter, suspension of urethra and other treatments;
  • 3\.Receiving treatment methods similar to acupuncture treatment principles (such as electroacupuncture, warm moxibustion, warm acupuncture, etc.) at present or within six months;
  • 4\.Complete urinary incontinence after prostate cancer surgery, that is, surgery to damage the pudendal nerve, complete loss of external urethral sphincter function through urodynamic test;
  • 5\.People with urinary tract infection (except those with asymptomatic lower urinary tract infection);
  • 6\.Known severe arrhythmia, severe cardiac insufficiency, acute myocarditis, constrictive pericarditis, pericardial tamponade, severe valvular disease, heart failure and other serious heart diseases;
  • 7\.Known liver injury or potentially serious liver disease (ALT or AST \> 10 times normal);
  • 8\.Known severe renal function impairment (eGFR \< 25mL/min/1\.73m2\), or planned or in dialysis, or acute contrast nephropathy at the time of screening;
  • 9\.Known other important organ dysfunction or severe primary diseases such as hematopoietic system;
  • 10\.Known coagulation dysfunction (with typical clinical diagnosis or clear laboratory test results);

Outcomes

Primary Outcomes

Not specified

Similar Trials